Drug intelligence / Profile preview

bicuculline

Development stage
Discontinued
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Intravenous, Intraperitoneal, Intracerebroventricular, Intracerebral
01

Overview

Bicuculline is a phthalide-isoquinoline alkaloid and a light-sensitive, competitive antagonist of Gamma-aminobutyric acid type A (GABAA) receptors. It was originally identified in 1932 from plant alkaloid extracts, including those from Dicentra cucullaria, Adlumia fungosa, and several Corydalis species. Bicuculline blocks the inhibitory action of GABA at ionotropic GABAA receptors—ligand-gated chloride channels that mediate neuronal inhibition—by binding competitively to the orthosteric site and stabilizing the receptor in a closed state. This antagonism leads to increased neuronal excitability and can induce convulsions; thus, bicuculline is widely used experimentally as a convulsant agent to model epilepsy *in vitro* (especially in hippocampal or cortical brain slices). In addition to its primary action on GABAA receptors, bicuculline also blocks small conductance calcium-activated potassium (SK) channels at higher concentrations[1][3][5][7].

Other names
(+)-bicuculline
02

Targets

GABRR (GABA-A receptor subunit rho)SK channel (Small-conductance calcium-activated potassium channel)

Beyond the preview

Go deeper on bicuculline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bicuculline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call